Page 7 - Cingulate Inc News Today

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Gainers Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday. Healthcare T...

Results Indicative that CTx-1301 Provides Entire Active-Day Efficacy with Optimal Onset and DurationKANSAS CITY, Kan., July 11, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its...

Cingulate Inc (NASDAQ: CING) announced topline results from its Phase 3 adult trial of its lead candidate, CTx-1301 (dexmethylphenidate) for attention-deficit/

Cingulate Inc. (NASDAQ:CING – Get Rating)’s share price traded down 14.4% during trading on Friday . The company traded as low as $0.84 and last traded at $0.84. 86,372 shares were traded during mid-day trading, a decline of 83% from the average session volume of 499,644 shares. The stock had previously closed at $0.98. Cingulate […]

KANSAS CITY, Kan., June 14, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a... | June 15, 2023

Cingulate Inc. (NASDAQ:CING – Get Rating) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 156,700 shares, a decrease of 45.5% from the April 30th total of 287,700 shares. Based on an average trading volume of 838,400 shares, the short-interest […]

KANSAS CITY, Kan., May 25, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a... | May 25, 2023

KANSAS CITY, Kan., May 25, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed...

FinancialContent fully hosted finance channel